Proxy Materials

ARS Pharmaceuticals, Inc. Filed 2022-07-21 Acc 0001193125-22-199252

Documents 1

2022-10-21 DEFA14A Proxy Materials
2022-07-21 DEFA14A Proxy Materials
2022-07-21 8-K Material agreement · Exit or restructuring costs · Executive or director change · Other events
2022-07-18 SC 13G Amended Statement of Ownership
2022-04-28 DEFA14A Proxy Materials

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading d379554ddefa14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…